openPR Logo
Press release

Genetic Screening Testing for Preventive Health Market Dynamics Shaped by Cost Reduction in NGS and Consumer Shift Toward Preventive Care

06-18-2025 09:23 AM CET | Health & Medicine

Press release from: Insightace Analytic Pvt Ltd.

Genetic Screening Testing for Preventive Health Market

Genetic Screening Testing for Preventive Health Market

the "Global Genetic Screening Testing for Preventive Health Market - By Test Type (Carrier Screening Tests (Expanded Carrier Screening, Targeted Carrier Screening), Non-Invasive Prenatal Tests, Preimplantation Genetic Testing, And Newborn Screening), Technology (NGS, Microarray, PCR, FISH), Application (Oncology, Cardiovascular Diseases, Reproductive Health, Neurodegenerative Health, Rare Diseases), And End-User (Hospitals And Diagnostic Laboratories, Dtc Companies, Genetic Counselling Services), Trends, Industry Competition Analysis, Revenue And Forecast To 2034."

Genetic Screening Testing for Preventive Health Market is predicted to grow at a 11.8% CAGR during the forecast period for 2025-2034.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2956

Genetic screening tests for preventive health are designed to assess an individual's genetic profile to identify potential predispositions to various hereditary diseases and conditions. These tests aim to provide early insight into the likelihood of developing chronic illnesses such as cancer, diabetes, cardiovascular disease, and other inherited disorders. The market for preventive genetic screening is driven by several key factors. Technological advancements, particularly in next-generation sequencing (NGS), have significantly improved the accuracy, affordability, and accessibility of these tests. Additionally, rising healthcare costs, a growing emphasis on preventive care, and increased public awareness regarding the advantages of early disease detection are contributing to the expanding adoption of genetic screening as a proactive health management tool.

List of Prominent Players in the Genetic Screening Testing for Preventive Health Market:
• Exact Science
• Labcorp Genetics Inc.
• Dante Labs US
• Myriad Genetics, Inc.
• Blueprint Genetics
• Ambry Genetics
• Revvity
• Laboratory Corporation of America Holdings
• BGI Group
• Genex Diagnostics Inc.
• Sonic Healthcare
• Fulgent Genetics

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-04

Market Dynamics
Drivers:
The market for genetic screening tests in preventive health is experiencing rapid growth, driven by advancements in technology, the increasing adoption of personalized medicine, and the rise of preventive healthcare initiatives. Factors such as escalating healthcare costs, a heightened focus on early detection, and increased public awareness of preventive strategies have further fueled demand. Additionally, the growing availability of direct-to-consumer (DTC) genetic testing has empowered individuals to take proactive steps in managing their health. Key stakeholders in this market include healthcare providers, hospitals, diagnostic laboratories, wellness-oriented organizations, and genetic testing companies. As the demand for personalized and data-driven healthcare solutions continues to rise, the adoption of genetic screening as a preventive tool is expected to accelerate.

Challenges:
Despite the promising outlook, several challenges hinder market growth. The high cost of advanced genetic testing remains a significant barrier to accessibility, particularly in low- and middle-income regions. Inconsistent insurance reimbursement policies further exacerbate financial constraints for many individuals. Additionally, the use of genetic data raises critical ethical and privacy concerns, prompting calls from both patients and regulatory bodies for enhanced data protection measures. Limited awareness and understanding of genetic screening among the general public and even some healthcare professionals also contribute to lower adoption rates.

Regional Trends:
North America is anticipated to dominate the global market for genetic screening in preventive health, supported by a robust healthcare infrastructure, high levels of consumer awareness, and ongoing technological innovation. The United States, in particular, plays a leading role due to its established healthcare system, substantial research activity in genetic testing, and increasing emphasis on personalized medicine. The presence of prominent direct-to-consumer testing companies, such as 23andMe, has further bolstered market growth. In Europe, countries such as France, Germany, and the United Kingdom have made significant investments in preventive healthcare, contributing to a substantial market share. Demand is particularly strong for genetic tests targeting cancer, cardiovascular diseases, and neurological disorders, and the region benefits from stringent medical regulations that support the advancement of genetic screening technologies.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2956

Segmentation of Genetic Screening Testing for Preventive Health Market-
By Test Type-
• Carrier Screening Test
o Expanded Carrier Screening
o Targeted Carrier Screening
• Non-Invasive Prenatal Test
• Preimplantation Genetic Testing
• Newborn Screening
By Technology-
• NGS
• Microarray
• PCR
• FISH
• Others
By Application-
• Oncology
• Cardiovascular Diseases
• Reproductive Health
• Neurodegenerative Health
• Rare Diseases
• Others
By End-User-
• Hospitals and Diagnostic Laboratories
• DTC Companies
• Genetic Counselling Services
• Other End-users
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa

Read Overview Report- https://www.insightaceanalytic.com/report/genetic-screening-testing-for-preventive-health-market/2956

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Genetic Screening Testing for Preventive Health Market Dynamics Shaped by Cost Reduction in NGS and Consumer Shift Toward Preventive Care here

News-ID: 4071701 • Views:

More Releases from Insightace Analytic Pvt Ltd.

Serotonin Supplement Market is on an Upward Growth Curve
Serotonin Supplement Market is on an Upward Growth Curve
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Serotonin Supplement Market- (By Functionality (Depression Relief, Insomnia Relief, Appetite Gaining, Mood Disorder Treatment, Weight Loss, and Cognitive Health Improvement), By Form (Tablets / Pills, Capsules, Liquid, Powder/ Chewable and Others), By Sales Channel (Hypermarkets / Supermarkets, Specialty Stores, E-commerce, Drug Stores & Pharmacies, Health & Wellness Stores, Convenience Stores, Departmental Stores and Others), By
RNAi Pesticides Market Report- Expansive Coverage on the Profit Sources
RNAi Pesticides Market Report- Expansive Coverage on the Profit Sources
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "RNAi Pesticides Market"-, By Application (Insect Pest Control, Weed Management, Disease Management, Resistance Management), By Crop Type (Agricultural Application, Non-Agricultural Application), By Product (Tropical RNAi Pesticide, Seed Embedded RANi, Transgenic RNAi, Others), By Formulation (Liquid Formulation, Granular Formulation, Powder Formulation, Others), Industry Trends, and Global Forecasts, 2025-2034 And Segment Revenue and Forecast To 2034." The RNAi
Rice Bran Wax Lubricant Market Future Trends and Scope Analysis Report
Rice Bran Wax Lubricant Market Future Trends and Scope Analysis Report
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Rice Bran Wax Lubricant Market - (By Grade (Food Grade, Industrial Grade, Pharmaceutical Grade), End-use (Automotive, Food and Beverage, Cosmetics and Personal Care, Pharmaceuticals, Chemicals, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the latest research by InsightAce Analytic, the Global Rice Bran Wax Lubricant Market is valued at US$ 394.6 million
RFCC Catalyst Market Report on the Untapped Growth Opportunities in the Industry
RFCC Catalyst Market Report on the Untapped Growth Opportunities in the Industry
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global RFCC Catalyst Market - (By Type (Zeolite, Non-Zeolite, Others), By Application (Heavy Gas Oil (HGO), Vacuum Gas Oil (VGO), Residue Feedstock, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the latest research by InsightAce Analytic, the Global RFCC Catalyst Market Size is valued at USD 229.4 Mn in 2023 and is predicted

All 5 Releases


More Releases for Genetic

Genetic Testing Market to Register Growth due to Increasing Prevalence of Geneti …
The prevalence of diseases, including chronic and genetic diseases, is rising at a swift pace. According to the World Health Organization, a genetic disorder named sickle cell anemia is primarily common among people who had ancestors in India, South America, Central America, Sub-Saharan Africa, Mediterranean countries (including Greece, Turkey, and Italy), Cuba, and Saudi Arabia. In addition to this, the high prevalence of chronic diseases, such as cancer, is also
Genetic Testing Market Demand 2018; by Method Molecular Genetic Test/ DNA Test, …
Universal Genetic Testing Market 2018 Research Report implements an exhaustive study on Market Research Future. This Report Cover Key Market Driver, market size, growth rate, opportunities, market Dynamics and Overall Analysis. And also cover the other information such as Genetic Testing market trends, Prominent players, chapter-wise Description followed by various user perceptions and Forecast till 2023. Genetic Testing Market - Global Insights The Global Genetic Testing Market is growing with the rapid
Global Preimplantation Genetic Testing Market: Growing Public-Private Investment …
The report "Preimplantation Genetic Testing Market by Products & Services (Reagents and Consumables, Software and Services and Instruments), Technology (Single-Nucleotide Polymorphism, Next-Generation Sequencing, Fluorescence in Situ Hybridization, Comparative Genomic Hybridization and Polymerase Chain Reaction), Procedure Type (Preimplantation Genetic Screening, and Preimplantation Genetic Diagnosis), Application (Single Gene Disorders, HLA Typing, Structural Chromosomal Abnormalities, X-Linked Disorders, Aneuploidy and Gender Identification), End User (Hospitals, Diagnostic Labs, and Service Providers, Research Laboratories & Academic
Reproductive Genetic Innovations to Discuss Novelties in Preimplantation Genetic …
Reproductive Genetic Innovations (RGI) will be attending and presenting at the 54th Mexican Congress of Reproductive Medicine hosted by the Associacion Mexicana de Medicina de la Reproduccion, A.C. (AMMR). This is the first year RGI has attended and presented at this conference. Booth G-H (July 17th to the 20th) President and Lab Director, Dr. Svetlana Rechitsky, will be giving a lecture on Wednesday afternoon (July 19th) titled, "Novelties in
Breast Cancer Predictive Genetic Testing Market Breast Cancer Predictive Genetic …
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Cancer Susceptibility Testing 1.1 Prologue to Cancer Susceptibility 1.2 Aspects of Cancer Susceptibility Testing Breast Cancer Susceptibility 2.1 Conceptual of Breast Cancer Susceptibility 2.2 Trail of the Inherited Susceptible Genes Hereditary Breast Cancer Genes 3.1 High Penetrant Genes 3.1.1 Breast Cancer Gene1 (BRCA1) 3.1.2 Breast Cancer Gene 2 (BRCA2)
Rising Prevalence of Genetic Disorders Propels Prenatal and New-born Genetic Tes …
Global Prenatal and New-born Genetic Testing Market: Snapshot Prenatal and new-born genetic tests refer to the systematic diagnostic tests and screenings undertaken to determine the risk of certain genetic disorders in newborn children and fetuses in stages as early as eight to ten weeks of gestation. The use of a variety of screening and diagnostic tools for detecting chromosomal abnormalities and the risk of diseases such as Patau syndrome, Down